Cerebellar Metastasis of Unknown Primary Neuroendocrine Carcinoma: Report of Case Mimicking Hemangioblastoma

被引:3
作者
Kuroda, Naoto [1 ]
Inenaga, Chikanori [1 ]
Arai, Yoshifumi [2 ]
Otsuki, Yoshiro [2 ]
Tanaka, Tokutaro [1 ]
机构
[1] Seirei Hamamatsu Gen Hosp, Dept Neurosurg, Naka Ku, Hamamatsu, Shizuoka, Japan
[2] Seirei Hamamatsu Gen Hosp, Dept Pathol, Naka Ku, Hamamatsu, Shizuoka, Japan
关键词
Brain metastasis; Cancer of unknown primary; Cerebellar metastasis; Neuroendocrine carcinoma; Neuroendocrine tumor; TUMORS; GUIDELINES; PET/CT; BRAIN;
D O I
10.1016/j.wneu.2019.05.104
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Neuroendocrine carcinoma (NEC) originates with neuroendocrine cells and is mainly found in the pancreas, lungs and gastrointestinal tract. We surgically treated a case of primary unknown NEC with only cerebral metastasis that mimicked hemangioblastoma. Recurrence was seen at the fornix, and no primary lesion had been identified as of 2 years after treatments despite careful examination. CASE DESCRIPTION: A 61-year-old man presented with dizziness. Past medical history included hypertension, dyslipidemia, hyperuricemia and colon polyp. We performed magnetic resonance imaging (MRI) to examine the cause of dizziness, revealing tumor with enhancement and peritumoral edema at the right cerebral lesion. Contrast-enhanced whole-body computed tomography (CT) showed no other lesions. We suspected hemangioblastoma from examinations and decided on surgical resection. Neuropathologically, the resected tumor was diagnosed as brain metastasis of NEC, but CT, fluorodeoxyglucose-positron emission tomography, gastrointestinal endoscopy, and somatostatin receptor scintigraphy all failed to reveal the primary lesion. As postoperative MRI showed enhancement around the resection cavity and at the right fornix, radiotherapy was performed. No other lesions were seen at 24 months post-operatively. We are continuing careful monitoring and no chemotherapy has been administered. CONCLUSIONS: We treated brain metastasis from NEC of unknown primary and mimicking hemangioblastoma using only local treatment. When an enhancing, single, solid tumor is seen in the cerebellum, brain metastasis from NEC of unknown primary is 1 differential diagnosis.
引用
收藏
页码:320 / 323
页数:4
相关论文
共 17 条
[1]   Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain [J].
Akimoto, Jiro ;
Fukuhara, Hirokazu ;
Suda, Tomohiro ;
Nagai, Kenta ;
Ichikawa, Megumi ;
Fukami, Shinjiro ;
Kohno, Michihiro ;
Matsubayashi, Jun ;
Nagao, Toshitaka .
BMC CANCER, 2016, 16
[2]   Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET [J].
Binderup, Tina ;
Knigge, Ulrich ;
Loft, Annika ;
Mortensen, Jann ;
Pfeifer, Andreas ;
Federspiel, Birgitte ;
Hansen, Carsten Palnaes ;
Hojgaard, Liselotte ;
Kjaer, Andreas .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (05) :704-712
[3]  
Brehar FM., 2013, ROMANIAN NEUROSURGER, V20, P159, DOI [10.2478/romneu-2013-0005, DOI 10.2478/ROMNEU-2013-0005]
[4]   The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin [J].
Kazmierczak, Philipp M. ;
Rominger, Axel ;
Wenter, Vera ;
Spitzweg, Christine ;
Auernhammer, Christoph ;
Angele, Martin K. ;
Rist, Carsten ;
Cyran, Clemens C. .
EUROPEAN RADIOLOGY, 2017, 27 (04) :1676-1684
[5]   SEOM clinical guideline on unknown primary cancer (2017) [J].
Losa, F. ;
Soler, G. ;
Casado, A. ;
Estival, A. ;
Fernandez, I. ;
Gimenez, S. ;
Longo, F. ;
Pazo-Cid, R. ;
Salgado, J. ;
Segui, M. A. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) :89-96
[6]   Single brain metastases of carcinoid tumors [J].
Maiuri, F ;
Cappabianca, P ;
De Caro, MD ;
Esposito, F .
JOURNAL OF NEURO-ONCOLOGY, 2004, 66 (03) :327-332
[7]   Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin [J].
Mitry, E ;
Baudin, E ;
Ducreux, M ;
Sabourin, JC ;
Rufié, P ;
Aparicio, T ;
Lasser, P ;
Elias, D ;
Duvillard, P ;
Schlumberger, M ;
Rougier, P .
BRITISH JOURNAL OF CANCER, 1999, 81 (08) :1351-1355
[8]   Feasibility and Efficacy of Combined Cisplatin and Irinotecan Chemotherapy for Poorly Differentiated Neuroendocrine Carcinomas [J].
Nakano, Kenji ;
Takahashi, Shunji ;
Yuasa, Takeshi ;
Nishimura, Noriko ;
Mishima, Yuko ;
Sakajiri, Sakura ;
Yokoyama, Masahiro ;
Tsuyama, Naoko ;
Ishikawa, Yuichi ;
Hatake, Kiyohiko .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (08) :697-703
[9]   SOMATOSTATIN RECEPTOR IMAGING OF NEUROENDOCRINE TUMORS WITH IN-111 PENTETREOTIDE (OCTREOSCAN) [J].
OLSEN, JO ;
POZDERAC, RV ;
HINKLE, G ;
HILL, T ;
ODORISIO, TM ;
SCHIRMER, WJ ;
ELLISON, EC ;
ODORISIO, MS .
SEMINARS IN NUCLEAR MEDICINE, 1995, 25 (03) :251-261
[10]   NEUROLOGIC COMPLICATIONS OF CARCINOID [J].
PATCHELL, RA ;
POSNER, JB .
NEUROLOGY, 1986, 36 (06) :745-749